SOLVED4999

he PMHNP Is treating a patient for severe, refractory depression. The PMHNP would like to change the pharmacologic choice to a monoamine oxidase Inhibitor (MAOI). The PHNP knows that to avoid drug-drug interactions, an appropriate amount of time should pass between the last dose of the current antidepressant and the first, dose of an MAOl. The amount of time to wait depends on the: • A – side effect profile of the current antidepressant. • b – class of the current antidepressant. • c – side effect profile of the MAOl. • D – half-life of the discontinued antidepressant.
SCIENCE
HEALTH SCIENCE
NURSING

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."